Cullinan Oncology (NASDAQ:CGEM – Free Report) had its price target decreased by HC Wainwright from $29.00 to $28.00 in a research report released on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several other equities analysts have also issued reports on CGEM. Jonestrading lifted their price objective on shares of […]
Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) have been given a consensus rating of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […]
Cullinan Oncology (NASDAQ:CGEM – Get Free Report) had its price objective decreased by stock analysts at HC Wainwright from $29.00 to $28.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 11.82% from the company’s current price. […]
Stifel Nicolaus initiated coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $40.00 price objective on the stock. Several other brokerages have also weighed in on CGEM. HC Wainwright decreased their price objective on Cullinan Oncology […]